GENOMEDX BIOSCIENCES
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
GENOMEDX BIOSCIENCES
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2008-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.genomedx.com
Total Employee:
51+
Status:
Closed
Contact:
626-529-0516
Email Addresses:
[email protected]
Total Funding:
50.74 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Google Google Cloud Microsoft DMARC
Current Advisors List
Current Employees Featured
Founder
Investors List
Aeris Capital
Aeris Capital investment in Venture Round - GenomeDx Biosciences
Merck
Merck investment in Series C - GenomeDx Biosciences
CRG
CRG investment in Debt Financing - GenomeDx Biosciences
Aeris Capital
Aeris Capital investment in Series B - GenomeDx Biosciences
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series B - GenomeDx Biosciences
Baird Capital
Baird Capital investment in Series B - GenomeDx Biosciences
CD-Venture
CD-Venture investment in Series B - GenomeDx Biosciences
Aeris Capital
Aeris Capital investment in Series A - GenomeDx Biosciences
CD-Venture
CD-Venture investment in Series A - GenomeDx Biosciences
Baird Capital
Baird Capital investment in Series A - GenomeDx Biosciences
Official Site Inspections
http://www.genomedx.com
- Host name: 84.46.239.3
- IP address: 84.46.239.3
- Location: Kaunas Republic of Lithuania
- Latitude: 54.9002
- Longitude: 23.9002
- Timezone: Europe/Vilnius
- Postal: 56001
More informations about "GenomeDx Biosciences"
GenomeDx Biosciences - Crunchbase Company Profile …
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership …See details»
GenomeDx Biosciences Inc. Information - RocketReach
GenomeDx is now Decipher Biosciences! Decipher Biosciences offers a portfolio of genomic tests, continues to build the GRID database of over 70,000 whole transcriptome profiles, and …See details»
Discover More with GeneDx - Experts in Genome & Exome Testing
GeneDx offers expert genome and exome sequencing to provide answers for patients and families seeking genetic testing.See details»
GenomeDx Biosciences Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GenomeDx Biosciences Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
GeneDx - Wikipedia
GeneDx is a genetic testing company that was founded in 2000 by two scientists from the National Institutes of Health (NIH), Sherri Bale and John Compton. [1] [2] [3 ...See details»
GenomeDx Biosciences Inc Careers and Employment - Indeed
Dec 4, 2019 GenomeDx curates the world’s most comprehensive genomic activity database on metastatic prostate cancer and couples it to cloud-based informatics to analyze millions of …See details»
GenomeDx Biosciences - 2025 Company Profile - Tracxn
Apr 11, 2025 GenomeDx Biosciences is a series C company based in San Diego (United States), founded in 2008 by Timothy Triche and Elai Davicioni. It operates as a Genomic tests …See details»
GenomeDx Biosciences - Overview, News & Similar companies
Who is GenomeDx Biosciences. GenomeDx Biosciences is a genomic information company changing the landscape of urologic cancer patient care with innovative genomic solutions that …See details»
GenomeDx Biosciences Inc. Management Team | Org Chart
GenomeDx Biosciences Inc. employs 110 employees. The GenomeDx Biosciences Inc. management team includes Robert Epstein (CEO), Edwin Hendrick (Chief Commercial …See details»
GenomeDx Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Genetic Testing Company Agrees to Pay $1.99 Million to Resolve ...
Feb 11, 2019 The Justice Department announced today that GenomeDx Biosciences Corp. (GenomeDx) has agreed to pay $1.99 million to resolve allegations that it violated the False …See details»
GDx · GenomeDx Biosciences Inc · 311 Water St, Unit 400
Overview . GenomeDx Biosciences Inc (operating as GDx) is a business in Vancouver licensed by the Business Licence Office of the Development, Buildings, and Licensing Division of the …See details»
GenomeDx Biosciences Closes Series A - Venture Capital Journal
Jan 9, 2012 GenomeDx Biosciences Inc. is a personalized medicine company focused on the development and commercialization of genomic based diagnostic and prognostic tools that …See details»
GenomeDx Biosciences Receives Accreditation from College of …
Jul 6, 2016 "GenomeDx is honored to achieve this prestigious accreditation from CAP and join the elite group of recognized facilities ... As the leading organization with more than 18,000 …See details»
Action Details - Office of Inspector General
Genetic Testing Company Agrees to Pay $1.99 Million to Resolve Allegations of False Claims to Medicare for Medically Unnecessary Tests. The Justice Department announced today that …See details»
GenomeDx | Whole Genome Sequencing for accurate diagnosis
GenomeDx with Diagnostic Interpretation is recommended for patients with a complex medical history or symptoms that suggests a genetic disease, even when other tests results have been …See details»
GeneDx CEO wants genetic testing for every newborn | AP News
The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news …See details»
GenomeDx Reviews: What Is It Like to Work At GenomeDx?
GenomeDx has an overall rating of 2.5 out of 5, based on over 17 reviews left anonymously by employees. 30% of employees would recommend working at GenomeDx to a friend and 30% …See details»
GenomeDx pays $2M to settle genetic test false claims allegations
Feb 13, 2019 GenomeDx’s Decipher test is designed to predict the probability that prostate cancer will metastasize after surgery and provide insights into the aggressiveness of the …See details»
Niagen Bioscience - Wikipedia
Niagen Bioscience has invested in research on nicotinamide riboside and its role in increasing NAD+ levels in the body. The company has partnered with multiple research institutions, such …See details»